Evaluation of Crohn’s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin
- 12 September 2013
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 24 (2) , 277-287
Abstract
To develop an MRI enterography global score (MEGS) of Crohn’s disease (CD) activity compared with a reference standard of faecal calprotectin (fC), C-reactive protein (CRP) and Harvey-Bradshaw index (HBI). Calprotectin, CRP and HBI were prospectively recorded for 71 patients (median age 33, male 35) with known/suspected CD undergoing MRI enterography. Two observers in consensus scored activity for nine bowel segments, grading mural thickness, T2 signal, mesenteric oedema, T1 enhancement and pattern, and haustral loss. Segmental scores were multiplied according to disease length. Five points each were added for lymphadenopathy, comb sign, fistulae and abscesses to derive the MEGS. A previously validated MRI CD activity score (CDAS) was also calculated. MRI scores were correlated with clinical references using Spearman’s rank. A logistic regression diagnostic model was built to discriminate active (fC > 100 μg/g) from inactive disease. MEGS and CDAS were significantly correlated with fC (r = 0.46, P < 0.001) and (r = 0.39, P = 0.001) respectively. MEGS correlated with CRP (r = 0.39, P = 0.002). The model for discriminating active from inactive disease achieved an area under the receiver-operating curve of 0.75 and 0.66 after leave-one-out analysis. A magnetic resonance enterography global score (MEGS) of CD activity correlated significantly with fC levels. • Magnetic resonance imaging is now widely used to assess Crohn’s disease. • Existing MRI activity scores depend on local segmental endoscopic/histological reference standards. • Scores including assessment of disease extent/complications better demonstrate full disease burden. • This new global Crohn’s disease burden score correlates with calprotectin and CRP. • The MRI enterography score of disease activity can complement existing clinical markers.Keywords
This publication has 38 references indexed in Scilit:
- Non-perforating small bowel Crohn's disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity indexEuropean Journal of Radiology, 2012
- Relative efficacy of different MRI signs in diagnosing active Crohn's disease, compared against a histological gold standardJournal of Medical Imaging and Radiation Oncology, 2011
- Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective studyEuropean Journal of Gastroenterology & Hepatology, 2010
- MR Enterographic Manifestations of Small Bowel Crohn DiseaseRadioGraphics, 2010
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current managementJournal of Crohn's and Colitis, 2010
- Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAIAmerican Journal of Gastroenterology, 2010
- Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findingsInflammatory Bowel Diseases, 2008
- Radiation Doses from Small-Bowel Follow-Through and Abdominopelvic MDCT in Crohn's DiseaseAmerican Journal of Roentgenology, 2007
- Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of GastroenterologyCanadian Journal of Gastroenterology and Hepatology, 2005
- Correlation between Faecal Excretion of Indium-111-Labelled Granulocytes and Calprotectin, a Granulocyte Marker Protein, in Patients with Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1999